TGF-β signaling has also been reported to promote the recruitment of MDSCs into tumors (72) and directly induce the generation of CD39+CD73+ myeloid cells in NSCLC patients via the activation of mTOR-HIF-1 signaling (73, 74) (Figure 1). This evidence concerns the gene ENTPD1 and non-small cell lung carcinoma.